RESUMO
The Epstein-Barr virus (also known as EBV), responsible for infectious mononucleosis, is a virus that infects the majority of the world's population. Infection occurs in several forms, most often asymptomatic, or as a fever accompanied by pharyngitis and lymphadenopathies. A rare complication of infectious mononucleosis is acute acalculous cholecystitis, an inflammation of the gallbladder characterized by ischaemia and severe cholestasis. The diagnosis of this pathology is made by imaging, but determining the cause may be tricky. We present here the case of acute acalculous cholecystitis in a 21-year-old woman. This case highlights a rare complication of EBV infection that is probably under-diagnosed, and demonstrates the usefulness of interpreting liver tests and leukocyte count in association with imaging findings.
Le virus d'Epstein-Barr (aussi appelé EBV), responsable de la mononucléose infectieuse, est un virus qui infecte la majorité de la population mondiale. L'infection se présente sous plusieurs formes, soit, le plus souvent, asymptomatique, soit avec une fièvre accompagnée d'une pharyngite et de lymphadénopathies. Une des rares complications de la mononucléose infectieuse est la cholécystite aiguë alithiasique, une inflammation de la vésicule biliaire, caractérisée par une ischémie et une cholestase importante. Le diagnostic de cette pathologie est réalisé par imagerie et la détermination de la cause peut s'avérer compliquée. Nous présentons ici le cas clinique d'une cholécystite aiguë alithiasique chez une jeune femme de 21 ans. Ce cas nous permet de mettre en lumière une complication rare de l'infection par l'EBV, probablement sous-diagnostiquée, et démontre l'utilité d'interpréter les tests hépatiques ainsi que la formule leucocytaire en relation avec les résultats d'une imagerie.
Assuntos
Colecistite Acalculosa , Mononucleose Infecciosa , Humanos , Mononucleose Infecciosa/complicações , Mononucleose Infecciosa/diagnóstico , Feminino , Adulto Jovem , Colecistite Acalculosa/diagnóstico , Colecistite Acalculosa/virologia , Colecistite Acalculosa/etiologia , Colecistite Aguda/diagnóstico , Colecistite Aguda/complicações , Colecistite Aguda/etiologiaRESUMO
The placement of a hip prosthesis is one of the most common orthopedic surgical procedures. Some implants contain metal and are therefore capable of releasing metal particles like cobalt in patients who wear metal prostheses. Cobalt can be responsible of local toxicity (including metallosis, hypersensitivity reaction, and benign tumor) or systemic toxicity (including cardiomyopathy, polycythemia, hypothyroidism, and neurological disorders). To monitor potential toxicity of metal hip prostheses, an annual monitoring of patients implanted is recommended and includes clinical examination, radiological examination and blood cobalt determination. The cobalt concentration in blood allows to estimate the risk of toxicity and to evaluate the performance of the implant. The currently recommended threshold value is equal to 7 µg of cobalt per liter of blood. Our study, conducted on 251 patients over a period of 4 years, has shown that the cobalt concentration average was 2.51 µg/l in blood, with 51 patients having a cobaltemia higher than the threshold of 7 µg/l.
Assuntos
Artroplastia de Quadril/efeitos adversos , Cobalto/efeitos adversos , Prótese de Quadril/efeitos adversos , Cobalto/farmacocinética , Cobalto/toxicidade , Humanos , Desenho de Prótese , Falha de PróteseRESUMO
Biological monitoring, also called biomonitoring, is a process to prevent and assess health risk for individuals exposed to chemical products present in environment or through workplace exposure. Biomonitoring is most often a monitoring of exposure or of effect. The exposure monitoring is currently the most widespread in toxicology. It involves the determination in biological fluids of different biomarkers, most of which are biomarkers of internal dose. These biological indicators are typically measured in blood and urine, but other biological samples can be analyzed. They are used to assess the penetration of environmental pollutants into the body. Assay results are interpreted in relation to reference values which are adapted either to occupationally exposed populations, or to general population. This interpretation and the choice of appropriate biomarker of exposure are not always obvious. Biomonitoring has some limitations despite its many advantages. It is complementary to another health prevention approach: the monitoring of ambient air. To illustrate in practice the biomonitoring of exposure, several examples of toxics and their associated biomarkers are reviewed: benzene, toluene, styrene, polycyclic aromatic hydrocarbons, chloroform, 2-hexanone and hydrogen cyanide.